How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease?

How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease?

Item
http://www.wikidata.org/entity/Q31979490
A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitusCost effectiveness of statins in coronary heart disease.The metabolic syndrome: pathophysiology, clinical relevance, and use of niacin.Effectiveness calculation in economic analysis: the case of statins for cardiovascular disease prevention.The Informatics for Diabetes and Education Telemedicine (IDEATel) projectCost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study.Columbia University's Informatics for Diabetes Education and Telemedicine (IDEATel) Project: rationale and design.Determining the cost-effectiveness of preventing cardiovascular disease: are estimates calculated over the duration of a clinical trial adequate?A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus: 5 year results of the IDEATel study.Benefits of pharmaceutical innovation: the case of simvastatin in Canada.A systematic literature review of methods of incorporating mortality in cost-effectiveness analyses of lipid-lowering therapies.Lipid-lowering treatment for all could substantially reduce the burden of macrovascular complications of diabetes patients in the Netherlands.Costs of dyslipidemia.Cost-effectiveness of HMG-CoA reductase inhibitors in the treatment of dyslipidemia and prevention of CHD.Daily dosing versus alternate-day dosing of simvastatin in patients with hypercholesterolemia.Aldo-keto reductase and sorbitol dehydrogenase enzymes in Egyptian diabetic patients with and without proliferative diabetic retinopathy.
P2860

How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease?

Item
http://www.wikidata.org/entity/Q31979490
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
How cost-effective is the trea ...... ithout cardiovascular disease?
@ast
How cost-effective is the trea ...... ithout cardiovascular disease?
@en
type
label
How cost-effective is the trea ...... ithout cardiovascular disease?
@ast
How cost-effective is the trea ...... ithout cardiovascular disease?
@en
prefLabel
How cost-effective is the trea ...... ithout cardiovascular disease?
@ast
How cost-effective is the trea ...... ithout cardiovascular disease?
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
How cost-effective is the trea ...... ithout cardiovascular disease?
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921